Pet Pharmaceuticals
Africa · 3 shared keywords
Updated
Reviewed by Vidhi Upadhyay
Africa Veterinary Drugs Market Industry Trends and Forecast to 2034: Segmented by (Product, Animal, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.
Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.
$855.7 Mn total, 2026–2034
| Year | Market size | Change that year | Since 2025 |
|---|---|---|---|
| 2024 (estimate) | $703.7 Mn | — | — |
| 2025 (base) | $764.9 Mn | +$61.2 Mn | — |
| 2026 (forecast) | $831.5 Mn | +$66.6 Mn | +8.7% |
| 2027 (forecast) | $903.8 Mn | +$72.3 Mn | +18.2% |
| 2028 (forecast) | $982.5 Mn | +$78.6 Mn | +28.4% |
| 2029 (forecast) | $1.07 Bn | +$85.5 Mn | +39.6% |
| 2030 (forecast) | $1.16 Bn | +$92.9 Mn | +51.8% |
| 2031 (forecast) | $1.26 Bn | +$101.0 Mn | +65% |
| 2032 (forecast) | $1.37 Bn | +$109.8 Mn | +79.3% |
| 2033 (forecast) | $1.49 Bn | +$119.3 Mn | +94.9% |
| 2034 (forecast) | $1.62 Bn | +$129.7 Mn | +111.9% |
Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.
| Market size, 2025 | $764.9 Mn placeholder estimate |
|---|---|
| Forecast, 2034 | $1.62 Bn placeholder estimate |
| Growth (CAGR), 2025–2034 | 8.7% placeholder estimate |
| Years | 2024 historical · 2025 base year · 2026–2034 forecast |
| Segments | Product and animal (see all) |
| Key players | Zoetis, Inc, Elanco, Merck & Co., Inc., Boehringer Ingelheim GmbH, Ceva Sante Animale and 1 more (see all) |
| Regulator in Africa | AMASource: African Union, African Medicines Agency treaty. Checked 14 Nov 2026. |
| Formats | PDF, PPTX, XLSX |
Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.
Veterinary drugs are the medicines given to pets and farm animals to treat or prevent disease and pain.
Key segments of the veterinary drugs market include product (Anti-Infectives, Anti-Parasitics and Anti-Inflammatories) and animal (Dogs, Cats and Cattle).
More pet ownership, spending on pet care, rising demand for meat and milk, and concern about animal disease are driving the veterinary drugs market.
Long-acting treatments, tests that find disease early and growing pet spending in emerging countries give the veterinary drugs market room to grow.
Rules on antibiotic use in farm animals, high drug prices for pet owners and shortages of vets in rural areas hold back the veterinary drugs market.
The veterinary drugs market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
The African Medicines Agency (AMA), set up by an African Union treaty in force since November 2021, aims to bring the work of national regulators together.[1] In some of the countries we cover here, medicines are approved by EDA (Egypt)[2], PPB (Kenya)[3], SAHPRA (South Africa)[4] and NAFDAC (Nigeria)[5]. How care is paid for in some of these countries: universal health insurance (Egypt)[6], the SHA (Kenya)[7], planned National Health Insurance (South Africa)[8] and out of pocket and the NHIA (Nigeria)[9].
[1] African Union, African Medicines Agency treaty. Checked 14 Nov 2026.
[2] Egyptian Drug Authority. Checked 14 Nov 2026.
[3] Pharmacy and Poisons Board. Checked 14 Nov 2026.
[4] South African Health Products Regulatory Authority. Checked 14 Nov 2026.
[5] NAFDAC. Checked 19 Nov 2026.
[6] Universal Health Insurance Authority. Checked 14 Nov 2026.
[7] Social Health Authority. Checked 14 Nov 2026.
[8] National Department of Health. Checked 14 Nov 2026.
[9] National Health Insurance Authority (NHIA). Checked 19 Nov 2026.
Regulators such as the US FDA, the European Medicines Agency and national drug authorities set approval, pricing and safety rules for veterinary drugs. Reimbursement decisions by public payers and insurers shape how fast new therapies reach patients in Africa.
What doctors and scientists are doing in Veterinary Drugs right now, from free public sources.
Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov. Fetched 21 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
Africa · 3 shared keywords
Africa · 1 shared keyword
Africa · 1 shared keyword
Africa · 1 shared keyword
Africa · 1 shared keyword
Africa · 1 shared keyword
OTC & Nutraceuticals · Africa
Public Health · Africa
Public Health · Africa
Healthcare Services · Africa
Public Health · Africa
Medical Devices · Africa